Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Main Authors: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
MDPI AG
2020-12-01
|
סדרה: | Vaccines |
נושאים: | |
גישה מקוונת: | https://www.mdpi.com/2076-393X/9/1/3 |
פריטים דומים
-
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
מאת: Robin John Shattock, et al.
יצא לאור: (2023-11-01) -
Vaccines’ New Era-RNA Vaccine
מאת: Wenshuo Zhou, et al.
יצא לאור: (2023-08-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
מאת: Dylan Kairuz, et al.
יצא לאור: (2022-10-01) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
מאת: Bruna Aparecida Souza Machado, et al.
יצא לאור: (2021-11-01) -
Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
מאת: Janne Snoeck, et al.
יצא לאור: (2023-11-01)